Thu.Feb 10, 2022

article thumbnail

Obesity is a public health problem

World of DTC Marketing

( Washington Post ) Obesity turned out to be a major risk factor for covid hospitalization and death, especially non-elderly. According to the CDC, it is linked to impaired immune function and decreased lung capacity; it can make ventilation more difficult. Once again, obesity indicates that it’s killing us. The United States might well have gotten through the pandemic at far lower cost, economic and human, without the decades-long obesity epidemic that preceded it.

Insurance 197
article thumbnail

Proud to be ranked in the Human Rights Campaign Foundation’s Corporate Equality Index 2022

Clarivate

This year Clarivate is proud to make a first appearance in the Human Rights Campaign Foundation’s Corporate Equality Index (CEI)—joining 1,271 major U.S. businesses that were ranked in 2022. This is an important first step in measuring our progress towards LGBTQ+ workplace equality. What is the Corporate Equality Index? Each year the Human Rights Campaign (HRC) runs the Corporate Equality Index benchmarking survey and report to measure corporate policies and practices related to LGBTQ+ wor

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Top 3 Things to Know About Engaging Oncologists in 2022

Pharma Marketing Network

Experts from top life sciences companies discussed strategies for more effectively engaging oncologists at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Here are the top three things to know about engaging oncologists in 2022: 1. Lead with clinical education. It’s no longer enough to build brand awareness, according to the panelists.

article thumbnail

Merck, Bristol-Myers Squibb, and Clarify discuss diversity in clinical trials

Clarify Health

Life science and healthcare industry leaders met at the 2021 CNS Summit to reflect on how pharmaceutical companies can leverage analytics and real-world evidence (RWE) to advance inclusion and diversity in clinical trials. A complete understanding of the differences in care, treatments, and outcomes is required to address the lack of diversity in clinical trials effectively.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

What Does Intouch Founder, CEO Have in Common With a Tennis Star?

Eversana Intouch

Just a little over three years ago, Intouch celebrated its twentieth anniversary. January 2019 … pre-COVID times, which means we were all together for a cake and champagne celebration marking the milestone. At the time, we had about 850 employees and offices in Kansas City, Chicago, and New York. But the plan was to keep growing, keep bringing in more talent.

article thumbnail

Merck, Bristol-Myers Squibb, and Clarify discuss diversity in clinical trials

Clarify Health

Life science and healthcare industry leaders met at the 2021 CNS Summit to reflect on how pharmaceutical companies can leverage analytics and real-world evidence (RWE) to advance inclusion and diversity in clinical trials. A complete understanding of the differences in care, treatments, and outcomes is required to address the lack of diversity in clinical [.].

More Trending

article thumbnail

2021 Innovation in South and Southeast Asia [REPORT]

Clarivate

As the pandemic persisted throughout 2021, organizations worldwide had to adapt and innovate. Download our report for insights into the South and Southeast Asia innovation landscape. Environmental and public health concerns continue to challenge organizations and leaders globally. Addressing these issues in recent years has tested resiliency and demonstrated the importance of adaptability and speed in innovation.

article thumbnail

Top 3 Things to Know About Preparing Your Pharma Marketing Team for Change in 2022

Pharma Marketing Network

Change champions from top life sciences companies discussed how to manage the constant wave of change pharma marketing teams are facing at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Here are the top three things to know about preparing your pharma marketing team for change in 2022: 1. Your marketing best practices still apply!

Pharma 52
article thumbnail

Social determinants of health: an economist’s view [PODCAST]

Clarivate

Matthew Arnold discusses social determinants of health with Dr Kenton Johnston, PhD, Associate Professor at Saint Louis University. Social determinants of health are increasingly focus for policy makers and patient advocates in the healthcare industries. They are looking beyond clinical environments for factors that can contribute to illness, whether that’s lack of health insurance or living in a so-called food desert without access to fresh produce and other health foods.

article thumbnail

Top 3 Things to Know About Pharma Social Media Trends in 2022

Pharma Marketing Network

Innovative social media marketers from top life sciences companies discussed the secrets to their success at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Here are the top three things to know about pharma social media trends in 2022: 1. Don’t be afraid to try new things. Social media trends change all the time, and pharma marketing organizations have to be nimble to make the most of them, according to Lauren Sacks , Director of Omnichannel Marketing at Biohaven Pharmaceu

Media 52
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Top 3 Things to Know About Preparing Your Pharma Marketing Team for Change in 2022

Pharma Marketing Network

Change champions from top life sciences companies discussed how to manage the constant wave of change pharma marketing teams are facing at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Here are the top three things to know about preparing your pharma marketing team for change in 2022: 1. Your marketing best practices still apply!

Pharma 52
article thumbnail

Top 3 Things to Know About Pharma Social Media Trends in 2022

Pharma Marketing Network

Innovative social media marketers from top life sciences companies discussed the secrets to their success at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Here are the top three things to know about pharma social media trends in 2022: 1. Don’t be afraid to try new things. Social media trends change all the time, and pharma marketing organizations have to be nimble to make the most of them, according to Lauren Sacks , Director of Omnichannel Marketing at Biohaven Pharmaceu

Media 52